- Home
- / Innovation Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Innovation Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$1 M
2024-10-29
Revenue
$18 K
FY, 2022
CreditSafe Score
?
Score changed on Jun 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 423.0K | 18.0K | ||||||||||
| General and administrative expense | 205.8K | 369.9K | 872.0K | 1.2M | 1.9M | 1.3M | 1.4M | 1.2M | 1.4M | 963.0K | 1.2M | 750.0K |
| Operating expense total | 838.6K | 1.9M | 7.2M | 11.7M | 10.9M | 14.1M | 12.8M | 5.5M | 4.2M | 6.0M | 2.0M | |
| Depreciation and amortization | 1.0K | |||||||||||
| EBIT | (4.2M) | (3.0M) | (8.0M) | (13.0M) | (12.7M) | (15.3M) | (13.9M) | (6.5M) | (4.6M) | (9.0M) | (6.9M) | (3.1M) |
| EBIT margin, % | -1095.7% | -38450.0% | ||||||||||
| Investment income | (22.0K) | (172.0K) | ||||||||||
| Interest income | 1.0K | 4.0K | 4.0K | 2.0K | 1.0K | |||||||
| Interest expense | 257.4K | 241.5K | 209.0K | 189.0K | 198.0K | 200.0K | 2.4M | 197.0K | 208.0K | 68.0K | 28.0K | |
| Pre tax profit | (4.9M) | (3.2M) | (8.2M) | (13.1M) | (12.9M) | (15.5M) | (16.4M) | (8.7M) | (6.6M) | (13.9M) | (7.0M) | (3.2M) |
| Net Income | (4.9M) | (3.2M) | (8.2M) | (13.1M) | (12.9M) | (15.5M) | (16.4M) | (8.7M) | (6.6M) | (13.9M) | 7.0M | (3.2M) |